Fig. 1From: Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitroTMZ and RG3 additively inhibited HUVEC proliferation. Cells were seeded in 24 well plates and treated with TMZ and/or RG3 for designated time and doses. a TMZ inhibited HUVEC proliferation in a time and dose dependent way. b RG3 inhibited HUVEC proliferation in a time and dose dependent way. c TMZ and RG3 additively inhibited proliferation of HUVECs. Bars with different letters indicate significant difference (P < 0.05) based on post-hoc Tukey analysisBack to article page